findmyKOL
Clinical trialNCT04152837TerminatedPhase 3Interventional

Safety of Lixivaptan in Subjects Previously Treated With Tolvaptan for Autosomal Dominant Polycystic Kidney Disease

SponsorPalladio BiosciencesEnrollment7ADPKDPolycystic Kidney Disease, Adult
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

6 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • University of California Los Angeles

    Los Angeles, California, United States

  • University of Chicago Medicine & Biological Sciences

    Chicago, Illinois, United States

  • Mayo Clinic

    Rochester, Minnesota, United States

  • Brookview Hills Research Associates, Llc

    Winston-Salem, North Carolina, United States

  • Northeast Clinical Research Center, Llc

    Bethlehem, Pennsylvania, United States

  • Nephrology Associates of Northern Virginia, Inc.

    Fairfax, Virginia, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
2 Sept 2020
Primary completion
29 Jul 2022
Completion
29 Jul 2022
Last update posted
10 Apr 2023
Registered enrollment
7
Registry id
NCT04152837

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.